Delivery Order SPE2DB22D2214-SPE2DB24FS5TR

Award Date 7/10/24
Potential Completion Date 7/31/24
Potential Value $8.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 400 MG VIALS to the Defense Logistics Agency (DLA). The contract, valued at $11,213.60, is a firm fixed price delivery order with a period of performance through July 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division involves the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR, a pharmaceutical product, to the Defense Logistics Agency (DLA) over a 2-year period from June 2024 to July 2024. The contract has a ceiling value of $8,379.09 and is structured as a firm-fixed price delivery order. Amerisourcebergen, a large pharmaceutical distribution company, is the prime contractor for this award, which is part of a larger...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price contract valued at $5,586.06. The contract has an ultimate completion date of July 30, 2024 and was awarded on July 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,379.09 and runs through July 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML medication. The contract, valued at $5,586.06, is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. It has an ultimate completion date of June 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 400 MG VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $12,595.00 and an ultimate completion date of June 18, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR medication. The contract, valued at $8,379.09, was awarded by the Defense Logistics Agency (DLA) and has a completion date of May 30, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $3,082.67 for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through February 3, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $16,758.18 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BENLYSTA 200 MG/ML AUTOINJECTML. The contract has a performance period through March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which does not have a set-aside designation. This award appears to be part of a larger indefinite delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, to the U.S. Defense Department's Medical Supply Chain agency. The $16,758.18 firm fixed-price delivery order contract has a completion date of May 6, 2024 and was awarded on April 15, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies globally, holds a significant Indefinite Delivery Contract...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB24FS5TR
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, to the Defense Logistics Agency (DLA) over a period ending on July 31, 2024. The firm-fixed-price contract has a ceiling value of $8,379.09. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award does not have a set-aside designation.

Generated 10/9/24, 9:15 AM